SLOT // FREE DEMO
Infectious 5 xWays has not gone through our rig yet. When it does, the full recorded session appears here: balance curve, hit rate, best win and the longest dry streak, published next to the official RTP above. Until then this page carries Nolimit City's own figures and a playable demo, and nothing of ours.
The RTP is 95.04%, which falls below the industry average of around 96%.
The maximum win is 55,555x the stake.
A free demo is available to try the game without risk.
Infectious 5 xWays drops you into a post-apocalyptic world. Nolimit City's August 2021 release mashes together caped crusaders and zombie outbreaks into a volatile package that demands respect.
The grid is 5x4 (expands up to 5x8) through the Expanding Grid mechanic. Ways determine wins, meaning matching symbols need only land on adjacent reels from left to right. The xWays system adds symbols that can split into multiple instances of a single pay symbol, increasing the ways count and win potential.
Free Spins form the core bonus attraction. Sticky Wilds stay in place for subsequent spins, and Multipliers amplify wins. The Buy Bonus option allows direct access to the bonus for players who prefer skipping the base-game grind.
At 95.04%, the RTP sits below the 96% industry average, meaning the game returns marginally less over theoretical long-term play. The very high volatility translates to brutal session profiles: long dry spells punctuated by explosive hits, requiring patience, bankroll headroom, and tolerance for variance. The 55,555x max win is genuinely enormous, placing Infectious 5 xWays in high-potential territory.
Superhero, post-apocalyptic, and zombie themes collide to create a grimy, fallen-civilization atmosphere.
Infectious 5 xWays is a 6/10 release: mechanically ambitious and capable of spectacular peaks, yet hampered by a below-average RTP and volatility that will alienate casual players. Still, this is a slot for the dedicated high-variance crowd. Try the free demo to gauge whether your temperament matches its demands.